Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-21-026712
Filing Date
2021-02-23
Accepted
2021-02-23 16:05:48
Documents
63
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tm214060d1_10k.htm 10-K 513410
2 EXHIBIT 4.1 tm214060d1_ex4-1.htm EX-4.1 38648
3 EXHIBIT 21.1 tm214060d1_ex21-1.htm EX-21.1 2545
4 EXHIBIT 23.1 tm214060d1_ex23-1.htm EX-23.1 3086
5 EXHIBIT 31.1 tm214060d1_ex31-1.htm EX-31.1 11914
6 EXHIBIT 31.2 tm214060d1_ex31-2.htm EX-31.2 11975
7 EXHIBIT 32.1 tm214060d1_ex32-1.htm EX-32.1 4680
8 EXHIBIT 32.2 tm214060d1_ex32-2.htm EX-32.2 4603
  Complete submission text file 0001104659-21-026712.txt   3351888

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT enzn-20201231.xml EX-101.INS 628390
10 XBRL TAXONOMY EXTENSION SCHEMA enzn-20201231.xsd EX-101.SCH 36451
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enzn-20201231_cal.xml EX-101.CAL 31131
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enzn-20201231_def.xml EX-101.DEF 119241
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE enzn-20201231_lab.xml EX-101.LAB 250429
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enzn-20201231_pre.xml EX-101.PRE 228830
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36435 | Film No.: 21665380
SIC: 2836 Biological Products, (No Diagnostic Substances)